StonvexLoading…
StonvexStonvexStonvexCore line items from XPEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $476.20M | $420.40M | $396.29M | $323.99M |
Operating Income | $62.65M | $59.15M | $66.97M | $53.94M |
Net Income | $51.23M | $45.49M | $52.80M | $41.38M |
EPS (Diluted) | $1.85 | $1.65 | $1.91 | $1.50 |
Total Assets | $382.53M | $285.61M | $252.04M | $193.36M |
Total Liabilities | $97.34M | $60.15M | $72.05M | $68.64M |
Cash & Equivalents | $50.86M | $22.09M | $11.61M | $8.06M |
Free Cash Flow OCF − CapEx | $62.93M | $41.11M | $31.03M | $4.12M |
Shares Outstanding | 27.60M | 27.65M | 27.63M | 27.62M |